{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02962591",
  "id": "02962591",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250626",
  "time": "1802",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250626/pdf/06l4t6mmpk3dfc.pdf",
  "summary": "### **Substantial Holder Notice Summary \u2013 Mayne Pharma Group Ltd**  \n\n- **Substantial Holder:** First Sentier Investors Holdings Pty Ltd (controlled by Mitsubishi UFJ Financial Group, Inc. *[MUFG]*)  \n- **Date of Becoming Substantial Holder:** 24/06/2025  \n- **Total Voting Power:** 5.05% (4,105,099 ordinary shares)  \n  - **Breakdown:**  \n    - Direct/controlled by First Sentier: 1,010,146 shares  \n    - Indirect (via MUFG): 3,094,953 shares  \n- **Key Registered Holders:** Citibank N.A. Hong Kong, National Australia Bank, others (see annexures).  \n- **Relevant Interest Basis:** Power to control voting/disposal via investment mandates (Corporations Act *s608(1)(b/c)*).  \n- **Recent Acquisitions:** Mixed cash/non-cash transactions (detailed in Annexure B).  \n\n**Material Impact:** Increased institutional ownership (MUFG-linked entity) may signal long-term strategic positioning. Disclosure confirms compliance without immediate capital structure changes.  \n\n*No material trading timetable or capital actions identified.*",
  "usage": {
    "prompt_tokens": 3451,
    "completion_tokens": 253,
    "total_tokens": 3704,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-26T08:46:02.084001"
}